20 Years of Pioneering Partnerships for Patient Impact
In 2026, Lygature marks 20 years of pioneering partnerships for patient impact.
As part of our anniversary year, we are sharing a an interactive timeline with 20 milestones and a series of stories highlighting the partnerships, initiatives, and expertise that have shaped our organization and contributed to health innovation over the past two decades.
Recent news
-
Lygature Newsletter: Highlights from Q2 2026
Lygature’s Q2 2026 Newsletter is now available, featuring highlights from across our partnerships and projects. -
Lygature LIVE 2026: Two Decades of Collaboration, Looking Ahead to Tomorrow’s Health
On 2 July, Lygature welcomed stakeholders from across academia, industry, patient organizations, and policymaking to its annual event, Lygature LIVE. View the aftermovie and read the full report below. -
Samen bouwen aan betere samenwerking: patiëntparticipatie centraal in PSM
Binnen Patiëntgerichte Samenwerking Medicijnen (PSM) werken patiëntenorganisaties en medicijnbedrijven samen aan één belangrijke ambitie: het patiëntperspectief structureel verankeren in de hele keten van medicijnontwikkeling tot gepast gebruik. Maar waarom is dat zo belangrijk en wat is er nodig om dat in de praktijk te realiseren?
Our value proposition
Accelerating the development of new medical solutions for patients
Lygature aims to accelerate the development of new medical solutions for patients by driving public-private collaboration between academia, industry and society. We are a not-for-profit organization that enables, drives and supports partnerships to address unmet medical needs.
-
Creating a safe space for innovation
-
Driving the partnership forward to deliver medical solutions
-
Providing specialized support for partnerships
Our projects
-
Oncode Institute
Outsmarting cancer, impacting lives -
CONTRAST 2.0
A multi-stakeholder effort continued from CONTRAST to develop innovative stroke treatments and how logistics of treatment can be improved. -
END2AMR
Accelerating novel therapies to tackle antimicrobial resistance and chronic bacterial infections -
Non-Biological Complex Drugs (NBCD) Working Group
Towards aligned, science-based approval and post-approval standards for non-biological complex drugs -
Prudent
-
BIGPICTURE
European Digital Pathology Platform for development and validation of Artificial Intelligence -
COREON
Committee and expert network of researchers on Regulation of Health Research -
Health Innovation Netherlands
Bringing Health Innovation to the next level -
AI4NTD
An international public-private collaboration working together to develop an automated AI-driven tool for the diagnosis and surveillance of neglected tropical diseases, at the first instance for soil-transmitted helminthiasis and schistosomiasis -
Regulatory Science Network Netherlands (RSNN)
Joining forces in the Netherlands to promote regulatory science and its application -
EPND
Accelerating the discovery of diagnostics and treatment for neurodegenerative diseases by removing barriers to data and sample sharing and fostering collaboration. -
IDERHA
Improving clinical decision-making and enhancing patient access to health innovations through better use of health data. -
GNA NOW
A European collaboration aimed at delivering Gram-negative antibacterials with new modes of action to the clinical phase. -
BBMRI.nl
Making biosamples, images and data findable, accessible and usable for health research. -
ReSToRe
Joining efforts to bring antigen-specific therapy for multiple sclerosis to the clinic -
PREDICTOM
Public private partnership to bring dementia diagnostics closer to the public through a customisable cognitive and biomarker screening platform.